Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemical modification of steffimycin B.

P F Wiley1, D W Elrod, D E Harper

  • 1Research Laboratories, Upjohn Company, Kalamazoo, Michigan 49001.

The Journal of Antibiotics
|March 1, 1988
PubMed
Summary

Researchers synthesized 15 new steffimycin B analogues. Three analogues showed significantly higher activity against P388 murine leukemia than the original compound, indicating potential for improved cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do signs of an effusion of the temporomandibular joint on magnetic resonance imaging correlate with signs and symptoms of temporomandibular joint disease?

The British journal of oral & maxillofacial surgery·2018
Same author

Conditioned pain modulation dampens the thermal grill illusion.

European journal of pain (London, England)·2017
Same author

Pain Mechanisms and Centralized Pain in Temporomandibular Disorders.

Journal of dental research·2016
Same author

Prediction of membrane protein types and subcellular locations.

Proteins·1999
Same author

Protein subcellular location prediction.

Protein engineering·1999
Same author

Using discriminant function for prediction of subcellular location of prokaryotic proteins.

Biochemical and biophysical research communications·1998

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Steffimycin B is an anthracycline antibiotic with known cytotoxic properties.
  • Anthracyclines are a critical class of anticancer agents used in chemotherapy.
  • Developing novel analogues can overcome resistance and improve therapeutic indices.

Purpose of the Study:

  • To synthesize and evaluate novel 3-substituted analogues of steffimycin B.
  • To identify analogues with enhanced anticancer activity against P388 murine leukemia.
  • To explore structure-activity relationships for steffimycin B derivatives.

Main Methods:

  • Synthesis of fifteen 3-substituted analogues of steffimycin B.
  • In vitro evaluation of compound cytotoxicity using the P388 murine leukemia cell line.
  • Comparative analysis of analogue activity against the parent compound.

Main Results:

  • Fifteen novel steffimycin B analogues were successfully synthesized.
  • Three analogues demonstrated substantially greater cytotoxic activity compared to steffimycin B.
  • These findings highlight specific structural modifications that enhance antileukemic potency.

Conclusions:

  • The synthesized 3-substituted analogues represent promising leads for new anticancer drug development.
  • Further investigation of these potent analogues is warranted for potential clinical application.
  • Structure-activity relationship studies can guide the design of more effective steffimycin B-based chemotherapeutics.

Related Experiment Videos